Virtual ISPOR Europe 2020
Congratulations to PRECISIONadvisors and PRECISIONheor for presenting more than a dozen posters and panels at Virtual ISPOR Europe 2020, 16 - 19 November, 2020.
Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016
Multiple factors have contributed to recent reductions in cancer mortality, including declines in smoking rates, treatment advances and better screening. But a key question remains: how much have recent developments in oncology treatments contributed to the decline of cancer mortality in the USA?
HLTH Conference Video: The Science & Politics of Developing a COVID-19 Vaccine & Treatment
Congratulations to Precision Medicine Group Co-Founder and CEO Mark Clein on his moderated Point: Counterpoint panel at this year’s HLTH Conference.
